summarize_cardiovascular_risk_signals

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

No annotations are provided, so the description must disclose behavior. It states the tool works on synthetic cases and is deterministic, but fails to explain what signals are summarized, data sources, or potential side effects (e.g., what happens with invalid input). The warning about clinical use is helpful but insufficient.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is exceptionally concise: two sentences that front-load the purpose and immediately provide usage guidance and a critical warning. No unnecessary words.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's simplicity (one parameter, output schema present), the description covers purpose, usage context, and limitations. It could benefit from clarifying 'deterministic risk signals' but is otherwise complete for a low-complexity tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The input schema has 0% description coverage, and the description does not mention the sole parameter 'case_id' at all. The title 'Case Id' in the schema provides minimal meaning, but the description adds no value beyond that.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states 'Summarize deterministic cardiovascular risk signals for a synthetic case' with specific use cases (STEMI, HF/Chagas, low-risk pattern triage), distinguishing it from sibling tools like 'interpret_12_lead_ecg' or 'list_synthetic_cases'.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides explicit usage guidance: 'Use for STEMI, HF/Chagas, or low-risk pattern triage' and includes a strong contraindication 'NOT for clinical use.' However, it does not mention alternatives or when not to use beyond clinical contexts.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.